Zheng Xiaoyu, director-general of China's State Administration of Medicines, has said that China's pharmaceutical industry is increasingly opening up to the outside world, particularly in terms of its exports, reports China Foreign Trade. At end-1995, China's drug industry had 1,500 foreign-funded joint ventures, with foreign funding in the sector exceeding $2.5 billion.
15 of the world's top 20 drug companies have a presence in China, while the sales value of foreign-funded pharmaceutical joint ventures accounted for 13% of the total Chinese drug industry last year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze